• Users Online: 512
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Safety and efficacy of Razumab – The new biosimilar in India: Our experience

Sameera V V, Apoorva A G, Joshi Shrinivas, Guruprasad A S

Year : 2016| Volume: 28| Issue : 3 | Page no: 180-185

   This article has been cited by
1 A Multicenter, Retrospective Study (RE-ENACT 2) on the Use of Razumab™ (World’s First Biosimilar Ranibizumab) in Wet Age-Related Macular Degeneration
Shashikant Sharma,Mujtaba Khan,Alok Chaturvedi
Ophthalmology and Therapy. 2019;
[Pubmed]  [Google Scholar] [DOI]
2 A Multinational Comparison of Anti-Vascular Endothelial Growth Factor Use: The United States, the United Kingdom, and Asia-Pacific
Ravi Parikh,Nathan Pirakitikulr,Jay Chhablani,Yoichi Sakurada,Rishi P. Singh,Yasha S. Modi
Ophthalmology Retina. 2018;
[Pubmed]  [Google Scholar] [DOI]


Read this article